Saturday, July 11, 2026

Drug profile · INN

minocycline

minocycline (AKAMIN 50) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 14
News articles 0
Drug details — minocycline

Quick answer

minocycline (AKAMIN 50) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN minocycline
Brand AKAMIN 50

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. FMX-101, 4% minocycline foam Phase 3 · VYNE Therapeutics · Acne Vulgaris
  2. FMX103 minocycline foam 1.5% Phase 3 · VYNE Therapeutics · Facial Papulopustular Rosacea
  3. METFORMIN for PASC: post-acute sequelae of SARS-CoV-2 infection Phase 3 · Disc Medicine · PASC: post-acute sequelae of SARS-CoV-2 infection
  4. Minocycline Hydrochloride Phase 2 · United Therapeutics Europe · Acute Pain
  5. Topical Minocycline Foam FXFM244 Phase 2 · VYNE Therapeutics · Rosacea
  6. Topical Minocycline Foam FXFM244 Phase 2 · VYNE Therapeutics · Acne Vulgaris
  7. Topical Minocycline Foam FXFM244 Phase 2 · VYNE Therapeutics · Impetigo
  8. glatiramer acetate with minocycline Phase 2 · Teva Pharma · Relapse Remitting Multiple Sclerosis

Frequently asked questions

What is minocycline?

minocycline (AKAMIN 50) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for minocycline?

AKAMIN 50 is a marketed brand name for minocycline. Check FDA Drugs@FDA for the current US label holder and prescribing information.